Fluorothymidine F-18
N/A
Report date: 2026/05/20 20:02:01
Base Information
Drug NameFluorothymidine F-18
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesDana-Farber Cancer InstituteUniversity of Texas Southwestern Medical CenterNational Cancer Institute
Inactive CompaniesUtah State UniversitySiemens Molecular Imaging IncWashington University School Of Medicine +[5]
Active Indications +[4]
Inactive Indications +[9]
Other Information
ATC CodeN/A
Related LinksWikipedia